CD19 and neoplasm: To mimic the exhaustion conditions encountered in patients with a high tumor burden, we performed repetitive, long-term in vitro stimulations of the CAR T cells over 24 to 33 days, with CD19+ or CD19- K562 cells added 1:1 to the T cell culture every three days (Fig. 1D).